VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
GALT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
GALTGalectin Therapeutics Inc.
$2.98$196M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksGALTQuarterly Balance Sheet

Galectin Therapeutics Inc. (GALT) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Galectin Therapeutics Inc. (GALT) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

GALT Balance Sheet

Quarterly statement

GALT Balance Sheet

Galectin Therapeutics Inc. (GALT) balance sheet — 26-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets12.9M14.66M15.69M19.44M12.73M15.43M9.29M17.25M28.67M27.29M25.46M27.71M21.61M19.47M19.55M20.55M17.12M25.79M33.51M41.82M
Cash & Short-Term Investments11.71M13.27M14.11M17.72M11.53M13.77M7.43M15.12M27.06M25.6M23.55M25.66M20.36M17.97M17.8M18.59M15.83M24.18M31.61M39.65M
Cash Only11.71M13.27M14.11M17.72M11.53M13.77M7.43M15.12M27.06M25.6M23.55M25.66M20.36M17.97M17.8M18.59M15.83M24.18M31.61M39.65M
Short-Term Investments00000000000000000000
Accounts Receivable00000000000000000000
Days Sales Outstanding--------------------
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets1.2M1.39M1.58M1.72M1.2M1.66M1.85M2.13M1.61M01.91M2.05M1.25M1.5M1.75M1.96M1.29M1.61M02.17M
Total Non-Current Assets104K167K68K96K136K175K243K243K306K368K430K490K552K613K673K733K793K101K108K7K
Property, Plant & Equipment00000000035K45K53K62K70673K00101K108K0
Fixed Asset Turnover--------------------
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments00000000000000000000
Other Non-Current Assets104K167K68K96K136K175K243K243K306K333K385K437K490K612.93K0733K793K007K
Total Assets13.01M14.83M15.76M19.53M12.87M15.6M9.53M17.5M28.97M27.66M25.89M28.2M22.16M20.08M20.23M21.29M17.91M25.89M33.62M41.83M
Asset Turnover--------------------
Asset Growth %1.12%-4.97%65.4%11.64%-55.6%-43.58%-63.2%-37.96%30.72%37.72%28.01%32.49%23.72%-22.43%-39.83%-49.11%-52.91%-22.51%46.81%41.31%
Total Current Liabilities46.41M151.62M7.31M8.03M136.44M10.77M110.84M35.41M25.26M14.62M12.63M15.68M10.52M9.95M11.53M13.01M9.59M10.89M9.54M9.03M
Accounts Payable3.5M3.73M3.12M3.25M5.39M5.87M6.53M5.66M2.79M3.7M3.8M6.43M2.68M1.98M2.55M3.89M2.35M2.96M1.91M1.8M
Days Payables Outstanding--------------------
Short-Term Debt33.21M137.7M00122.28M097.11M21.12M10.52M00000000000
Deferred Revenue (Current)03K000000000000000000
Other Current Liabilities13.2M6.14M545K1.06M4.84M844K852K1.89M1.42M63K518K8.07M857K7.29M386K8.11M751K7.38M300K6.49M
Current Ratio0.28x0.10x2.15x2.42x0.09x1.43x0.08x0.49x1.13x1.87x2.02x1.77x2.05x1.96x1.70x1.58x1.79x2.37x3.51x4.63x
Quick Ratio0.28x0.10x2.15x2.42x0.09x1.43x0.08x0.49x1.13x1.87x2.02x1.77x2.05x1.96x1.70x1.58x1.79x2.37x3.51x4.63x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities42K59K138.69M137.7M1.72M122M10.95M85.16M96.19M95.19M84.34M72.77M62.51M61.26M51.34M40.47M30.66M30.22M30.27M30.18M
Long-Term Debt00135.71M133.74M0120.46M10.81M85.11M94.04M93.42M82.46M71.74M61.14M60.36M49.94M39.83M29.73M29.5M29.27M29.05M
Capital Lease Obligations00000000007K20K32K055K077K87K00
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities42K59K2.98M3.96M1.72M1.54M136K47K2.16M1.76M1.87M1M1.34M896K1.34M639K850K626K998K1.13M
Total Liabilities46.45M151.68M146M145.73M138.17M132.77M121.79M120.56M121.45M109.8M96.98M88.44M73.04M71.21M62.87M53.48M40.25M41.11M39.81M39.21M
Total Debt33.21M137.7M135.72M133.76M122.31M120.51M107.99M106.25M104.59M93.47M82.52M71.81M61.22M60.4M50.04M39.87M29.85M29.62M29.29M29.06M
Net Debt21.5M124.43M121.61M116.04M110.79M106.74M100.56M91.13M77.53M67.87M58.96M46.15M40.85M42.44M32.24M21.28M14.02M5.44M-2.32M-10.59M
Debt / Equity-------------------11.11x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage--0.41x-1.54x-1.84x-3.50x-3.12x-4.52x-5.94x-6.51x-8.75x-9.92x-10.80x-11.49x-13.02x-24.06x-33.53x-30.96x-40.98x-42.75x-25.55x
Total Equity-33.44M-136.85M-130.24M-126.19M-125.3M-117.17M-112.26M-103.07M-92.48M-82.15M-71.09M-60.24M-50.87M-51.13M-42.65M-32.19M-22.34M-15.22M-6.19M2.62M
Equity Growth %73.31%-16.8%-16.01%-22.44%-35.49%-42.63%-57.92%-71.1%-81.79%-60.67%-66.69%-87.12%-127.77%-235.85%-588.62%-1330.66%-341.49%-188.94%-133.96%-89.19%
Book Value per Share-0.37-2.08-1.98-1.97-1.95-1.85-1.78-1.64-1.48-1.32-1.15-1.00-0.85-0.86-0.72-0.54-0.38-0.26-0.100.04
Total Shareholders' Equity-33.44M-136.85M-130.24M-126.19M-125.3M-117.17M-112.26M-103.07M-92.48M-82.15M-71.09M-60.24M-50.87M-51.13M-42.65M-32.19M-22.34M-15.22M-6.19M2.62M
Common Stock100K66K65K65K64K63K63K62K62K62K61K61K61K59K59K59K59K59K59K59K
Retained Earnings-450.36M-446.79M-437.61M-432.55M-426.98M-418.76M-411.18M-401.57M-389.54M-378.3M-365.87M-354.37M-344.31M-330.27M-321.09M-309.57M-298.87M-290.29M-280.61M-270.69M
Treasury Stock00000000000000000000
Accumulated OCI00000000000-61K0-510K000000
Minority Interest00000000000000000000